Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02933112 · ClinicalTrials.gov registry record · NA

Workflow Validation of an In-home Auto-titrating Mandibular Positioner

A NA study of Obstructive Sleep Apnea, sponsored by Zephyr Sleep Technologies.

Completed
Registry status
NA
Development phase
71
Enrollment target
1
Study location

NCT02933112 is a NA study of Obstructive Sleep Apnea that has completed, run by Zephyr Sleep Technologies. The registered enrollment target is 71 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02933112, a NA study of Obstructive Sleep Apnea, has completed, sponsored by Zephyr Sleep Technologies.

COMPLETED
Registry status
NA
Development phase
71 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to test the workflow of an auto-titrating mandibular positioner in its intended setting. Participants with obstructive sleep apnea will use the device to determine their eligibility for oral appliance therapy and provide feedback on usability of the device.

Conditions Studied

Interventions

  • DEVICE Auto-titrating mandibular positioner test

Study Locations (1)

Washington

  • Premier Sleep - Bellevue

Trial Details

FieldValue
Enrollment Target 71 participants
Start Date 2016-10
Est. Completion 2018-10-11
Phase NA

Sponsor

Zephyr Sleep Technologies

4 total trials

What the Registry Record Tells You About NCT02933112

The ClinicalTrials.gov registry entry for NCT02933112 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (68% lower). The listed sponsor is Zephyr Sleep Technologies, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which Auto-titrating mandibular positioner test is the first listed.

NCT02933112 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT02933112 about?

NCT02933112 is a clinical study titled "Workflow Validation of an In-home Auto-titrating Mandibular Positioner". The purpose of the study is to test the workflow of an auto-titrating mandibular positioner in its intended setting. Participants with obstructive sleep apnea will use the device to determine their eligibility for oral appliance therapy and provide feedback on usability of the device.

What is the current status of trial NCT02933112?

This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2016-10. Estimated completion is 2018-10-11.

What conditions does trial NCT02933112 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea.

What interventions are being tested in trial NCT02933112?

The interventions under investigation include: Auto-titrating mandibular positioner test (DEVICE).

Who is sponsoring clinical trial NCT02933112?

This trial is sponsored by Zephyr Sleep Technologies, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02933112 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.